The DOI matches its Crossref record; 671 of the 685 references it cites were found in a registry or an index, and 14 are not checked yet.
From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics
Open accessAbstract
Central nervous system disorders drive disability, yet many neuroactive candidates fail because the brain is a hard compartment to dose. Plant-derived molecules spanning polyphenols, alkaloids, terpenoids, and cannabinoids are attractive because their pleiotropic actions can engage oxidative stress, neuroinflammation, and circuit dysfunction. In practice, the blood–brain barrier (BBB) restricts most native phytochemicals through tight-junction selectivity, rapid metabolism, low solubility, and transporter-mediated efflux. Key gaps include poor standardization of exposure metrics, limited human-relevant BBB models, and few head-to-head studies that compare delivery platforms on the same payload and outcome. This review tackles the mismatch between mechanistic promise and reliable brain exposure that stalls translation. The objectives are to link phytochemical liabilities to enabling strategies in nanomedicine, alternative routes, and transporter-targeted prodrugs, and to propose decision-grade endpoints for translation. We synthesize evidence on BBB transport logic, nanocarrier families, targeting ligands, intranasal delivery, focused ultrasound-mediated opening, and prodrug approaches that hijack influx transporters, while foregrounding safety and chemistry, manufacturing, and controls (CMC) constraints. Here we highlight that effective neurotherapeutics emerge when chemistry, carrier, route, and measurement are co-designed rather than optimized in isolation. This framework can guide platform selection, de-risk first in-human studies, and sharpen trial endpoints. More broadly, it offers a transferable playbook for barrier-limited drug development across neurology, psychiatry, and oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, BBB constraints remain a central translational hurdle [126].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [126]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.230s · Cited by 4,219
TEER Measurement Techniques for In Vitro Barrier Model Systems
Srinivasan, B., Kolli, A. R., Esch, M. B., Abaci, H. E., Shuler, M. L., & Hickman, J. J. (2015) · SLAS Technology · doi:10.1177/2211068214561025 · Cited by 2,145
Steinmetz, J. D., Seeher, K. M., Schiess, N., Nichols, E., Cao, B., Servili, C., Cavallera, V., Cousin, E., Hagins, H., Moberg, M. E., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00038-3 · Cited by 2,019
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
The Immunomodulatory and Anti-Inflammatory Role of Polyphenols
Yahfoufi, N., Alsadi, N., Jambi, M., & Matar, C. (2018) · Nutrients · doi:10.3390/nu10111618 · Cited by 1,737
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease.
Marucci, G., Buccioni, M., Ben, D. D., Lambertucci, C., Volpini, R., & Amenta, F. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108352 · Cited by 1,147
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01614 · Cited by 1,086
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
Lipsman, N., Meng, Y., Bethune, A. J., Huang, Y., Lam, B., Masellis, M., Herrmann, N., Heyn, C., Aubert, I., Boutet, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04529-6 · Cited by 950
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Quantifying the global burden of mental disorders and their economic value
Arias, D., Saxena, S., & Verguet, S. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101675 · Cited by 771
Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility
Weber, M., Steinle, H., Golombek, S., Hann, L., Schlensak, C., Wendel, H. P., & Avci-Adali, M. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00099 · Cited by 728
Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake
Kimiz-Gebologlu, I., & Oncel, S. S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.027 · Cited by 722
Mechanism of intranasal drug delivery directly to the brain
Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.025 · Cited by 721
Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.014 · Cited by 718
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
Current hurdles to the translation of nanomedicines from bench to the clinic
Đorđević, S., Gonzalez, M. M., Conejos-Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi-Fainaro, R., Florindo, H. F., & Vicent, M. J. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 657
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Revisiting the neurovascular unit
Schaeffer, S., & Iadecola, C. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00904-7 · Cited by 649
Mainprize, T., Lipsman, N., Huang, Y., Meng, Y., Bethune, A., Ironside, S., Heyn, C., Alkins, R., Trudeau, M., Sahgal, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36340-0 · Cited by 618
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Duan, Y., Dhar, A., Patel, C., Khimani, M., Neogi, S., Sharma, P., Siva Kumar, N., & Vekariya, R. L. (2020) · RSC Advances · doi:10.1039/d0ra03491f · Cited by 614
Kapetanovic, I. M., Muzzio, M., Huang, Z., Thompson, T. N., & McCormick, D. L. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1525-4 · Cited by 609
Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine
Hade, M. D., Suire, C. N., & Suo, Z. (2021) · Cells · doi:10.3390/cells10081959 · Cited by 607
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · doi:10.20944/preprints201810.0507.v1 · Cited by 605
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040218 · Cited by 603
Park, T.-E., Mustafaoglu, N., Herland, A., Hasselkus, R., Mannix, R., FitzGerald, E. A., Prantil-Baun, R., Watters, A., Henry, O., Benz, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10588-0 · Cited by 594
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Das, S. S., Bharadwaj, P., Bilal, M., Barani, M., Rahdar, A., Taboada, P., Bungau, S., & Kyzas, G. Z. (2020) · Polymers · doi:10.3390/polym12061397 · Cited by 581
Stimuli‐responsive liposomes for drug delivery
Lee, Y., & Thompson, D. H. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1450 · Cited by 579
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Singh, D. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02565-0 · Cited by 569
Waterhouse, R. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.014 · Cited by 567
Wang, Y. I., Abaci, H. E., & Shuler, M. L. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26045 · Cited by 563
ABC Transporters and the Blood-Brain Barrier
Begley, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 545
Tapeinos, C., Battaglini, M., & Ciofani, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.033 · Cited by 539
Carbon quantum dots and their biomedical and therapeutic applications: a review
Molaei, M. J. (2019) · RSC Advances · doi:10.1039/c8ra08088g · Cited by 538
pH-responsive polymer nanoparticles for drug delivery
Deirram, N., Zhang, C., Kermaniyan, S. S., Johnston, A. P. R., & Such, G. K. (2019) · Macromolecular Rapid Communications · doi:10.1002/marc.201800917 · Cited by 531
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Exosome mimetics: a novel class of drug delivery systems
Schiffelers, R., Kooijmans, S., Vader, van Dommelen, & Solinge, V. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29661 · Cited by 512
Furukawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg303 · Cited by 507
Davis, K. D., Aghaeepour, N., Ahn, A. H., Angst, M. S., Borsook, D., Brenton, A., Burczynski, M. E., Crean, C., Edwards, R., Gaudilliere, B., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0362-2 · Cited by 496
Hersh, A. M., Alomari, S., & Tyler, B. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084153 · Cited by 478
Lochhead, J. J., Yang, J., Ronaldson, P. T., & Davis, T. P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00914 · Cited by 445
Exosome engineering: Current progress in cargo loading and targeted delivery
Fu, S., Wang, Y., Xia, X., & Zheng, J. C. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100261 · Cited by 444
Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain
Patel, M. M., & Patel, B. M. (2017) · CNS Drugs · doi:10.1007/s40263-016-0405-9 · Cited by 430
Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery
Rayamajhi, S., Nguyen, T. D. T., Marasini, R., & Aryal, S. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.054 · Cited by 429
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Current Strategies for Exosome Cargo Loading and Targeting Delivery
Zeng, H., Guo, S., Ren, X., Wu, Z., Liu, S., & Yao, X. (2023) · Cells · doi:10.3390/cells12101416 · Cited by 424
External triggering and triggered targeting strategies for drug delivery
Wang, Y., & Kohane, D. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.20 · Cited by 418
Adaptive platform trials: definition, design, conduct and reporting considerations
Coalition, T. A. P. T. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0034-3 · Cited by 412
Janaszewska, A., Lazniewska, J., Trzepiński, P., Marcinkowska, M., & Klajnert-Maculewicz, B. (2019) · Biomolecules · doi:10.3390/biom9080330 · Cited by 409
Role of Monocarboxylate Transporters in Drug Delivery to the Brain
Vijay, N., & Morris, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990462 · Cited by 408
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Santos, T. C. D., Gomes, T. M., Pinto, B. A. S., Camara, A. L., & Paes, A. M. D. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01192 · Cited by 389
Lian, M. Q., Chng, W. H., Liang, J., Yeo, H. Q., Lee, C. K., Belaid, M., Tollemeto, M., Wacker, M. G., Czarny, B., & Pastorin, G. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12283 · Cited by 388
Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications
Guo, M., Sun, X., Chen, J., & Cai, T. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.030 · Cited by 386
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378
Gribkoff, V. K., & Kaczmarek, L. K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.021 · Cited by 371
Targeting the transferrin receptor for brain drug delivery
Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 370
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Patching, S. G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9672-6 · Cited by 361
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
Bien-Ly, N., Yu, Y. J., Bumbaca, D., Elstrott, J., Boswell, C. A., Zhang, Y., Luk, W., Lu, Y., Dennis, M. S., Weimer, R. M., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131660 · Cited by 353
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
Cho, C.-F., Wolfe, J. M., Fadzen, C. M., Calligaris, D., Hornburg, K., Chiocca, E. A., Agar, N. Y. R., Pentelute, B. L., & Lawler, S. E. (2017) · Nature Communications · doi:10.1038/ncomms15623 · Cited by 336
Polyphenols and bioavailability: an update
Teng, H., & Chen, L. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1437023 · Cited by 336
Mehta, A. M., Sonabend, A. M., & Bruce, J. N. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0520-4 · Cited by 331
Focused ultrasound-mediated drug delivery through the blood–brain barrier
Burgess, A., Shah, K., Hough, O., & Hynynen, K. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1028369 · Cited by 323
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
Gasca-Salas, C., Fernández-Rodríguez, B., Pineda-Pardo, J. A., Rodríguez-Rojas, R., Obeso, I., Hernández-Fernández, F., del Álamo, M., Mata, D., Guida, P., Ordás-Bandera, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21022-9 · Cited by 319
Meng, Q., Wang, A., Hua, H., Jiang, Y., Wang, Y., Mu, H., Wu, Z., & Sun, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151474 · Cited by 310
Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
Dobrovolskaia, M. A., & McNeil, S. E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.025 · Cited by 309
Costa, C. P., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 303
The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An In Vivo Study
Betzer, O., Shilo, M., Opochinsky, R., Barnoy, E., Motiei, M., Okun, E., Yadid, G., & Popovtzer, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0022 · Cited by 301
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 298
Truskewycz, A., Yin, H., Halberg, N., Lai, D. T. H., Ball, A. S., Truong, V. K., Rybicka, A. M., & Cole, I. (2022) · Small · doi:10.1002/smll.202106342 · Cited by 296
Targeted liposomal drug delivery: a nanoscience and biophysical perspective
Liu, Y., Castro Bravo, K. M., & Liu, J. (2021) · Nanoscale Horizons · doi:10.1039/d0nh00605j · Cited by 294
Sánchez-López, E., Ettcheto, M., Egea, M. A., Espina, M., Cano, A., Calpena, A. C., Camins, A., Carmona, N., Silva, A. M., Souto, E. B., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0356-z · Cited by 291
Sivadasan, D., Sultan, M. H., Madkhali, O., Almoshari, Y., & Thangavel, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081291 · Cited by 288
Bioinspired exosome-like therapeutics and delivery nanoplatforms
Lu, M., & Huang, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119925 · Cited by 282
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Habault, J., & Poyet, J.-L. (2019) · Molecules · doi:10.3390/molecules24050927 · Cited by 280
Wang, C., Tsai, T., & Lee, C. (2024) · Clinical and Translational Science · doi:10.1111/cts.13904 · Cited by 280
Transport of small molecules through the blood-brain barrier: biology and methodology
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00003-p · Cited by 279
Biosafety of mesoporous silica nanoparticles; towards clinical translation
Lérida-Viso, A., Estepa-Fernández, A., García-Fernández, A., Martí-Centelles, V., & Martínez-Máñez, R. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115049 · Cited by 279
Nanoformulations to Enhance the Bioavailability and Physiological Functions of Polyphenols
Yang, B., Dong, Y., Wang, F., & Zhang, Y. (2020) · Molecules · doi:10.3390/molecules25204613 · Cited by 278
Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development
Grabska-Kobyłecka, I., Szpakowski, P., Król, A., Książek-Winiarek, D., Kobyłecki, A., Głąbiński, A., & Nowak, D. (2023) · Nutrients · doi:10.3390/nu15153454 · Cited by 273
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Recent Applications of PLGA in Drug Delivery Systems
Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268
Bridging barriers: a comparative look at the blood–brain barrier across organisms
O'Brown, N. M., Pfau, S. J., & Gu, C. (2018) · Genes & Development · doi:10.1101/gad.309823.117 · Cited by 263
Review on the Scale-Up Methods for the Preparation of Solid Lipid Nanoparticles
Khairnar, S. V., Pagare, P., Thakre, A., Nambiar, A. R., Junnuthula, V., Abraham, M. C., Kolimi, P., Nyavanandi, D., & Dyawanapelly, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091886 · Cited by 263
Koffie, R. M., Farrar, C. T., Saidi, L.-J., William, C. M., Hyman, B. T., & Spires-Jones, T. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111405108 · Cited by 260
Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., Gomez, C., Bebawy, J. F., Liu, B. P., Bouchoux, G., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00112-2 · Cited by 260
Exosome-Based Drug Delivery: Translation from Bench to Clinic
Koh, H. B., Kim, H. J., Kang, S.-W., & Yoo, T.-H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082042 · Cited by 259
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Bhattacharya, T., Soares, G. A. B. E., Chopra, H., Rahman, M. M., Hasan, Z., Swain, S. S., & Cavalu, S. (2022) · Materials · doi:10.3390/ma15030804 · Cited by 259
Sun, T., Zhang, Y., Power, C., Alexander, P. M., Sutton, J. T., Aryal, M., Vykhodtseva, N., Miller, E. L., & McDannold, N. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713328114 · Cited by 258
Engineered human blood–brain barrier microfluidic model for vascular permeability analyses
Hajal, C., Offeddu, G. S., Shin, Y., Zhang, S., Morozova, O., Hickman, D., Knutson, C. G., & Kamm, R. D. (2022) · Nature Protocols · doi:10.1038/s41596-021-00635-w · Cited by 257
Dogra, P., Adolphi, N. L., Wang, Z., Lin, Y.-S., Butler, K. S., Durfee, P. N., Croissant, J. G., Noureddine, A., Coker, E. N., Bearer, E. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06730-z · Cited by 257
Why nanoparticles prefer liver macrophage cell uptake in vivo
Ngo, W., Ahmed, S., Blackadar, C., Bussin, B., Ji, Q., Mladjenovic, S. M., Sepahi, Z., & Chan, W. C. W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114238 · Cited by 256
Hoshi, Y., Uchida, Y., Tachikawa, M., Inoue, T., Ohtsuki, S., & Terasaki, T. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23575 · Cited by 254
A Novel Transwell Blood Brain Barrier Model Using Primary Human Cells
Stone, N. L., England, T. J., & O’Sullivan, S. E. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00230 · Cited by 251
Heterogeneity of the blood-brain barrier
Wilhelm, I., Nyúl-Tóth, Á., Suciu, M., Hermenean, A., & Krizbai, I. A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1143544 · Cited by 247
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications
Tian, J., Han, Z., Song, D., Peng, Y., Xiong, M., Chen, Z., Duan, S., & Zhang, L. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s444582 · Cited by 246
Magnetic iron oxide nanoparticles for brain imaging and drug delivery
Qiao, R., Fu, C., Forgham, H., Javed, I., Huang, X., Zhu, J., Whittaker, A. K., & Davis, T. P. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114822 · Cited by 245
Lipophilicity in PK design: methyl, ethyl, futile
van de Waterbeemd, H., Smith, D. A., & Jones, B. C. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008192010023 · Cited by 244
Guttikonda, S. R., Sikkema, L., Tchieu, J., Saurat, N., Walsh, R. M., Harschnitz, O., Ciceri, G., Sneeboer, M., Mazutis, L., Setty, M., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00796-z · Cited by 243
Cannabinoids: Therapeutic Use in Clinical Practice
Pagano, C., Navarra, G., Coppola, L., Avilia, G., Bifulco, M., & Laezza, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063344 · Cited by 240
Chen, C., Duan, Z., Yuan, Y., Li, R., Pang, L., Liang, J., Xu, X., & Wang, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b15831 · Cited by 239
Wei, Y., Quan, L., Zhou, C., & Zhan, Q. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0040 · Cited by 234
In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4
Seyfert, U. T., Biehl, V., & Schenk, J. (2002) · Biomolecular Engineering · doi:10.1016/s1389-0344(02)00015-1 · Cited by 232
Convection-enhanced delivery to the central nervous system
Lonser, R. R., Sarntinoranont, M., Morrison, P. F., & Oldfield, E. H. (2015) · Journal of Neurosurgery · doi:10.3171/2014.10.jns14229 · Cited by 230
pH-Responsive Polymeric Micelle Carriers for siRNA Drugs
Convertine, A. J., Diab, C., Prieve, M., Paschal, A., Hoffman, A. S., Johnson, P. H., & Stayton, P. S. (2010) · Biomacromolecules · doi:10.1021/bm100652w · Cited by 228
Kalvass, J. C., Maurer, T. S., & Pollack, G. M. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012294 · Cited by 227
Drug and gene delivery across the blood–brain barrier with focused ultrasound
Timbie, K. F., Mead, B. P., & Price, R. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.059 · Cited by 227
Magnetic targeting of nanoparticles across the intact blood–brain barrier
Kong, S. D., Lee, J., Ramachandran, S., Eliceiri, B. P., Shubayev, V. I., Lal, R., & Jin, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.021 · Cited by 226
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
Zelepukin, I. V., Shevchenko, K. G., & Deyev, S. M. (2024) · Nature Communications · doi:10.1038/s41467-024-48838-5 · Cited by 224
Advances in Microfluidic Blood–Brain Barrier (BBB) Models
Oddo, A., Peng, B., Tong, Z., Wei, Y., Tong, W. Y., Thissen, H., & Voelcker, N. H. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.04.006 · Cited by 221
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Zhu, Y., Liu, C., & Pang, Z. (2019) · Biomolecules · doi:10.3390/biom9120790 · Cited by 220
Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 216
Plant-Derived Extracellular Vesicles as Therapeutic Nanocarriers
Karamanidou, T., & Tsouknidas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010191 · Cited by 216
Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies
Jahangiri, A., Chin, A. T., Flanigan, P. M., Chen, R., Bankiewicz, K., & Aghi, M. K. (2017) · Journal of Neurosurgery · doi:10.3171/2016.1.jns151591 · Cited by 212
Machine learning for synergistic network pharmacology: a comprehensive overview
Noor, F., Asif, M., Ashfaq, U. A., Qasim, M., & Tahir ul Qamar, M. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad120 · Cited by 211
Carbon quantum dots in bioimaging and biomedicines
Das, S., Mondal, S., & Ghosh, D. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1333752 · Cited by 210
The “Neuro-Glial-Vascular” Unit: The Role of Glia in Neurovascular Unit Formation and Dysfunction
Kugler, E. C., Greenwood, J., & MacDonald, R. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732820 · Cited by 209
Choudhury, H., Pandey, M., Chin, P. X., Phang, Y. L., Cheah, J. Y., Ooi, S. C., Mak, K.-K., Pichika, M. R., Kesharwani, P., Hussain, Z., et al. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0552-2 · Cited by 209
Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review
Meng, X., Shen, Y., Zhao, H., Lu, X., Wang, Z., & Zhao, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02859-w · Cited by 209
Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery
Vazana, U., Veksler, R., Pell, G. S., Prager, O., Fassler, M., Chassidim, Y., Roth, Y., Shahar, H., Zangen, A., Raccah, R., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0587-16.2016 · Cited by 205
Polyphenols: From Classification to Therapeutic Potential and Bioavailability
Ciupei, D., Colișar, A., LEOPOLD, L. F., Stănilă, A., & Diaconeasa, Z. M. (2024) · Foods · doi:10.3390/foods13244131 · Cited by 205
L-Type amino acid transporter 1 as a target for drug delivery
Puris, E., Gynther, M., Auriola, S., & Huttunen, K. M. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02826-8 · Cited by 205
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
Friedman, D., French, J. A., & Maccarrone, M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30032-8 · Cited by 203
Chen, K.-T., Chai, W.-Y., Lin, Y.-J., Lin, C.-J., Chen, P.-Y., Tsai, H.-C., Huang, C.-Y., Kuo, J. S., Liu, H.-L., & Wei, K.-C. (2021) · Science Advances · doi:10.1126/sciadv.abd0772 · Cited by 202
Wakaskar, R. R. (2018) · Journal of Drug Targeting · doi:10.1080/1061186x.2017.1367006 · Cited by 201
Zhang, W., Liu, Q. Y., Haqqani, A. S., Leclerc, S., Liu, Z., Fauteux, F., Baumann, E., Delaney, C. E., Ly, D., Star, A. T., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00209-0 · Cited by 200
Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
Teleanu, R. I., Preda, M. D., Niculescu, A.-G., Vladâcenco, O., Radu, C. I., Grumezescu, A. M., & Teleanu, D. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050987 · Cited by 200
Drug loading techniques for exosome-based drug delivery systems.
Xi, X.-M., Xia, S.-J., & Lu, R. (2021) · PubMed · doi:10.1691/ph.2021.0128 · Cited by 200
Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss
Mäe, M. A., He, L., Nordling, S., Vazquez-Liebanas, E., Nahar, K., Jung, B., Li, X., Tan, B. C., Chin Foo, J., Cazenave-Gassiot, A., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317473 · Cited by 199
Linville, R. M., DeStefano, J. G., Sklar, M. B., Xu, Z., Farrell, A. M., Bogorad, M. I., Chu, C., Walczak, P., Cheng, L., Mahairaki, V., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.023 · Cited by 199
Fridén, M., Gupta, A., Antonsson, M., Bredberg, U., & Hammarlund-Udenaes, M. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015222 · Cited by 199
Biswas, P., Dey, D., Biswas, P. K., Rahaman, T. I., Saha, S., Parvez, A., Khan, D. A., Lily, N. J., Saha, K., Sohel, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911746 · Cited by 199
Cells of the Blood–Brain Barrier: An Overview of the Neurovascular Unit in Health and Disease
McConnell, H., & Mishra, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2289-6_1 · Cited by 198
Ahmad, A., Imran, M., & Sharma, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112463 · Cited by 198
Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications
Shilo, M., Motiei, M., Hana, P., & Popovtzer, R. (2014) · Nanoscale · doi:10.1039/c3nr04878k · Cited by 193
Manufacturing Therapeutic Exosomes: from Bench to Industry
Ahn, S.-H., Ryu, S.-W., Choi, H., You, S., Park, J., & Choi, C. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.2033 · Cited by 191
Characterization of Nanoparticle Batch-To-Batch Variability
Mülhopt, S., Diabaté, S., Dilger, M., Adelhelm, C., Anderlohr, C., Bergfeldt, T., Gómez de la Torre, J., Jiang, Y., Valsami-Jones, E., Langevin, D., et al. (2018) · Nanomaterials · doi:10.3390/nano8050311 · Cited by 190
In-vitro blood–brain barrier modeling: A review of modern and fast-advancing technologies
Sivandzade, F., & Cucullo, L. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18788769 · Cited by 189
Chen, T., Dai, Y., Hu, C., Lin, Z., Wang, S., Yang, J., Zeng, L., Li, S., & Li, W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00557-1 · Cited by 189
Vigani, B., Rossi, S., Sandri, G., Bonferoni, M. C., Caramella, C. M., & Ferrari, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090859 · Cited by 188
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Huang, Y.-S., Ogbechi, J., Clanchy, F. I., Williams, R. O., & Stone, T. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00388 · Cited by 187
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 184
Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies
Kurz, C., Walker, L., Rauchmann, B., & Perneczky, R. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12782 · Cited by 183
Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
Crowe, T. P., & Hsu, W. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030629 · Cited by 183
Zhang, Q.-L., Fu, B. M., & Zhang, Z.-J. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1346002 · Cited by 180
Laurindo, L. F., Dias, J. A., Araújo, A. C., Pomini, K. T., Galhardi, C. M., Detregiachi, C. R. P., Haber, L. S. D. A., Roque, D. D., Bechara, M. D., de Castro, M. V. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 179
Self-citationLiu, X., Van Natta, K., Yeo, H., Vilenski, O., Weller, P. E., Worboys, P. D., & Monshouwer, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024125 · Cited by 179
A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors
Meng, F., Xi, Y., Huang, J., & Ayers, P. W. (2021) · Scientific Data · doi:10.1038/s41597-021-01069-5 · Cited by 179
Fong, C. W. (2015) · The Journal of Membrane Biology · doi:10.1007/s00232-015-9778-9 · Cited by 178
Intranasal Insulin for Alzheimer’s Disease
Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 177
Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics
Nicolaescu, O. E., Belu, I., Mocanu, A. G., Manda, C. V., Rău, G., Pîrvu, A. S., Ionescu, C., Ciulu-Costinescu, F., Popescu, M., & Ciocîlteu, M. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030288 · Cited by 176
Current regulatory landscape of nanomaterials and nanomedicines: A global perspective
Ali, F., Neha, K., & Parveen, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104118 · Cited by 176
Koo, J., Lim, C., & Oh, K. T. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s439181 · Cited by 174
Kopustinskienė, D. M., Masteiková, R., Lažauskas, R., & Bernatonienė, J. (2022) · Antioxidants · doi:10.3390/antiox11040660 · Cited by 173
Verma, N., & Arora, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17080990 · Cited by 173
Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System
Ojeda-Hernández, D. D., Canales-Aguirre, A. A., Matias-Guiu, J., Gomez-Pinedo, U., & Mateos-Díaz, J. C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00389 · Cited by 172
Juhairiyah, F., & de Lange, E. C. M. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00648-z · Cited by 172
Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway
Chen, Y., Zhang, C., Huang, Y., Ma, Y., Song, Q., Chen, H., Jiang, G., & Gao, X. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115196 · Cited by 172
Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system
Wang, C., Xue, Y., Markovic, T., Li, H., Wang, S., Zhong, Y., Du, S., Zhang, Y., Hou, X., Yu, Y., et al. (2025) · Nature Materials · doi:10.1038/s41563-024-02114-5 · Cited by 171
Cornelissen, F. M. G., Markert, G., Deutsch, G., Antonara, M., Faaij, N., Bartelink, I. H., Noske, D. P., Vandertop, W. P., Bender, A., & Westerman, B. A. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01824 · Cited by 171
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 170
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery
Kim, W., Ly, N. K., He, Y., Li, Y., Yuan, Z., & Yeo, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114635 · Cited by 170
Reed, M. J., Damodarasamy, M., & Banks, W. A. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1651157 · Cited by 169
Convection-enhanced drug delivery for glioblastoma: a review
D’Amico, R. S., Aghi, M. K., Vogelbaum, M. A., & Bruce, J. N. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03408-9 · Cited by 168
Laurindo, L. F., Santos, A. R. D. O. D., Carvalho, A. C. A. D., Bechara, M. D., Guiguer, E. L., Goulart, R. D. A., Vargas Sinatora, R., Araújo, A. C., & Barbalho, S. M. (2023) · Metabolites · doi:10.3390/metabo13010096 · Cited by 166
Self-citationAstrocyte-derived Wnt growth factors are required for endothelial blood-brain barrier maintenance
Guérit, S., Fidan, E., Macas, J., Czupalla, C. J., de Figueiredo, R. M., Vijikumar, A., Yalcin, B. H., Thom, S., Winter, P., Gerhardt, H., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101937 · Cited by 164
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier
Keaney, J., Walsh, D. M., O’Malley, T. T., Hudson, N., Crosbie, D. E., Loftus, T., Sheehan, F., McDaid, J., Humphries, M. M., Callanan, J. J., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500472 · Cited by 164
Chen, K.-T., Wei, K.-C., & Liu, H.-L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00086 · Cited by 164
Chen, C., Sun, M., Wang, J., Su, L., Lin, J., & Yan, X. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12163 · Cited by 163
van Gerven, J., & Bonelli, M. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13550 · Cited by 162
Loryan, I., Reichel, A., Feng, B., Bundgaard, C., Shaffer, C. L., Kalvass, C., Bednarczyk, D., Morrison, D., Lesuisse, D., Hoppe, E., et al. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03246-6 · Cited by 162
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
Huang, Q., Chen, Y., Zhang, W., Xia, X., Li, H., Qin, M., & Gao, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.054 · Cited by 162
Wang, J., Li, Z., Pan, M., Fiaz, M., Hao, Y., Yan, Y., Sun, L., & Yan, F. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114539 · Cited by 161
Regulatory Considerations, Challenges and Risk-based Approach in Nanomedicine Development
Csóka, I., Ismail, R., Jójárt‐Laczkovich, O., & Pallagi, E. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210406115529 · Cited by 161
Natural polyphenol disposition via coupled metabolic pathways
Liu, Z., & Hu, M. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.3.389 · Cited by 159
Cunha, S., Costa, C. P., Loureiro, J. A., Alves, J., Peixoto, A. F. R. O., Forbes, B., Lobo, J. M. S., & Silva, A. C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070599 · Cited by 156
Liu, X., & Meng, H. (2021) · View · doi:10.1002/viw.20200190 · Cited by 155
Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection
Arias-Sánchez, R. A., Torner, L., & Navarro, B. F. (2023) · Molecules · doi:10.3390/molecules28145415 · Cited by 154
Pfau, S. J., Langen, U. H., Fisher, T. M., Prakash, I., Nagpurwala, F., Lozoya, R., Lee, W.-C. A., Wu, Z., & Gu, C. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01743-y · Cited by 153
Kafa, H., Wang, J. T.-W., Rubio, N., Klippstein, R., Costa, P. M., Hassan, H. A. F. M., Sosabowski, J. K., Bansal, S. S., Preston, J. E., Abbott, N. J., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.031 · Cited by 153
Central nervous system delivery of molecules across the blood-brain barrier
Gosselet, F., Loiola, R. A., Roig, A., Rosell, A., & Culot, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104952 · Cited by 153
Nguyen, T., & Maeng, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030572 · Cited by 152
Ranjbar, S., Emamjomeh, A., Sharifi, F., Zarepour, A., Aghaabbasi, K., Dehshahri, A., Sepahvand, A. M., Zarrabi, A., Beyzaei, H., Zahedi, M. M., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071944 · Cited by 152
Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 151
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease
Leta, V., Klingelhoefer, L., Longardner, K., Campagnolo, M., Çotur, H., Aureli, F., Metta, V., Bhidayasiri, R., Chung‐Faye, G., Falup‐Pecurariu, C., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15734 · Cited by 151
Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma
Narsinh, K. H., Perez, E., Haddad, A. F., Young, J. S., Savastano, L. E., Villanueva-Meyer, J. E., Winkler, E. A., & de Groot, J. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01338-x · Cited by 151
Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?
Mamun, A. A., Shao, C., Geng, P., Wang, S., & Xiao, J. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90982 · Cited by 150
Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery
Kesharwani, P., Gothwal, A., Iyer, A. K., Jain, K., Chourasia, M. K., & Gupta, U. D. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.009 · Cited by 148
Cited by
Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration
Mózes, N., Varga, J. T., Szwajgier, D., Kryczyk‐Poprawa, A., Zábó, V., Lehoczki, A., Lipécz, Á., Csípő, T., Fazekas‐Pongor, V., Major, D., et al. (2026) · Nutrients · doi:10.3390/nu18091470 · Cited by 5
“Certain low-molecular-weight polyphenols, particularly flavonoid aglycones, may cross the BBB via passive diffusion or transporter-mediated mechanisms, although evidence in humans remains limited [139].”
Li, Y., Luo, R., Li, Y., Liu, Z., Duan, X., Qin, S., He, Z., & Liu, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119888 · Cited by 3
Zamani, N. I. S. M., Hamezah, H. S., Mediani, A., Ghazali, M., Sadikan, M. Z., & Jam, F. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-53311-y · Cited by 2
“To overcome these limitations, nanoparticle-based delivery systems have been widely explored to enhance brain targeting and improve central nervous system (CNS) bioavailability of polyphenolic compounds 51 .”
Dakanalis, A., Papadopoulou, S. Κ., Mentzelou, M., Migdanis, A., Migdanis, I., & Giaginis, C. (2026) · Nutrients · doi:10.3390/nu18142362 · Cited by 3
Uti, D. E., Alum, E. U., Okpe, J. M., Egbung, J. E., & Mbah, J. O. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103524 · Cited by 1
Metadata
- Authors
- Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., & Barbalho, S. M.
- Affiliations
- University of Szeged (HU)
- Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Marília, Universidade de Marília (UNIMAR), Marilia 17525-902, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Graduate Program in Structural and Functional Interactions in Rehabilitation, School of Medicine, Universidade de Marília (UNIMAR), Marilia 17525-902, SP, Brazil
- Corresponding author
- Tanaka, Masaru
- Barbalho, Sandra Maria
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2026-03-03
- Volume
- 27
- Issue
- 5
- Pages
- 2370
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC12985693
- OpenAlex
- W7133487442
- Cited by
- 13
- References
- 654
- Citations by year
- 2026: 13
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- HUN-REN Hungarian Research Network (-)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- blood-brain barrier, polyphenols, prodrugs, phytochemicals, nanocarriers, neurotherapeutics, intranasal drug delivery, focused ultrasound, BBB transporters, tight junctions, brain exposure, drug delivery routes, neuroinflammation, oxidative stress
- MeSH terms
- Animals, Blood-Brain Barrier, Central Nervous System Diseases, Humans, Prodrugs, Drug Delivery Systems, Nanomedicine, Polyphenols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.